Heart transplantation in infants with idiopathic hypertrophic cardiomyopathy

Abstract:  Whereas it is well known that idiopathic HCM can present in newborns and infants, little information is available on HT in this very young age group. We report a series of 17 infants with idiopathic HCM, including two neonates with rapidly progressive severe HF for whom HT was necessary. When HF manifests in a newborn/infant with idiopathic HCM and extreme cavity size reduction, the possibility of a rapidly progressive clinical course should be anticipated and HT may become the only available therapeutic solution.

[1]  E. Puffenberger,et al.  Homozygosity for a novel splice site mutation in the cardiac myosin‐binding protein C gene causes severe neonatal hypertrophic cardiomyopathy , 2007, American journal of medical genetics. Part A.

[2]  S. Colan,et al.  Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry , 2007, Circulation.

[3]  W. Manning,et al.  Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy , 2006, Circulation.

[4]  R. L. Lekanne Deprez,et al.  Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene , 2006, Journal of Medical Genetics.

[5]  G. Boriani,et al.  Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. , 2005, Journal of the American College of Cardiology.

[6]  J. Dearani,et al.  Septal myectomy for obstructive hypertrophic cardiomyopathy in pediatric patients: early and late results. , 2005, The Annals of thoracic surgery.

[7]  J. Carlin,et al.  Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study , 2005, Circulation.

[8]  J. Carlin,et al.  Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study , 2005, Circulation.

[9]  M. Carrier,et al.  Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  John B Carlin,et al.  The epidemiology of childhood cardiomyopathy in Australia. , 2003, The New England journal of medicine.

[11]  E. Holme,et al.  Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. , 2003, European heart journal.

[12]  J. Smallhorn,et al.  Fetal Cardiomyopathies: Pathogenic Mechanisms, Hemodynamic Findings, and Clinical Outcome , 2002, Circulation.

[13]  C. Wippermann,et al.  Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe , 2000, Heart.

[14]  J. Skinner,et al.  A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants. , 1997, Heart.

[15]  W. Roberts,et al.  Hypertrophic Cardiomyopathy in Infants: Clinical Features and Natural History , 1982, Circulation.